Proliferation markers and survival in early breast cancer: A systematic review and meta-analysis of 85 studies in 32,825 patients
Top Cited Papers
Open Access
- 1 August 2008
- journal article
- review article
- Published by Elsevier in The Breast
- Vol. 17 (4) , 323-334
- https://doi.org/10.1016/j.breast.2008.02.002
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancerGenome Biology, 2007
- Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?Nature Reviews Cancer, 2007
- Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patientsBritish Journal of Cancer, 2007
- Molecular Classification and Molecular Forecasting of Breast Cancer: Ready for Clinical Application?Journal of Clinical Oncology, 2005
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Prognostic value of proliferation in invasive breast cancer: a reviewJournal of Clinical Pathology, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67Breast Cancer Research and Treatment, 2000
- The utility of mitotic index, oestrogen receptor and Ki-67 measurements in the creation of novel prognostic indices fornode-negative breast cancerEuropean Journal of Surgical Oncology, 1999
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986